Skip to content
TB
Company

Updated:

Translate Bio, Inc.

Translate Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001693415, and its reported industry is...

Overview

Translate Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001693415, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2021-03-01, it reported annual revenue of USD 138,811,000; net income of USD -53,787,000; total assets of USD 889,936,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Translate Bio, Inc.
Former names in filing history
RaNA Therapeutics, Inc. (2017-01-05 to 2017-01-05)
Classification
Company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Lexington, MA, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001693415

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2020USD$138.8M-$53.8M$889.9M$342.0M$236.3M
FY2019USD$7.8M-$113.3M$336.2M$84.6M-$82.2M
FY2018USD$1.4M-$97.4M$287.7M$55.2M-$22.1M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
SC 13D—SCHEDULE 13D
SC 13D—SC 13D
10-Q10-Q
8-K8-K
8-K8-K
10-Q10-Q
8-K8-K
DEF 14ADEF 14A
8-K8-K
10-K10-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Translate Bio, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Translate Bio, Inc. | Lexington Company | Altss